Home / Drug shortages / Belladonna and Opium Suppository

Belladonna and Opium Suppository — FDA Drug Shortage

To Be Discontinued — Padagis US LLC

The FDA lists a drug shortage record for Belladonna and Opium Suppository (suppository) from Padagis US LLC with status To Be Discontinued. The shortage was first posted on 07/23/2026.

Shortage Details

Status
To Be Discontinued
Company
Padagis US LLC
Package NDC
0574-7045-12
Dosage Form
Suppository
Presentation
Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12)
Initial Posting
07/23/2026
Revised Date

FDA data resources